Amlodipine, a commonly prescribed medication for managing high blood pressure and angina, is available from various pharmaceutical brands known for their quality and efficacy. As a generic medication, it is produced by numerous manufacturers, offering a range of options that meet different preferences and needs. While some patients might turn to well-established names for peace of mind, others may focus on cost-effective alternatives that deliver the same therapeutic benefits. To help you navigate the options and make an informed choice, explore our curated list of leading amlodipine brands below.
Illustration of amlodipine
Best brands of amlodipine in 2025
Norvasc
Norvasc, a brand of amlodipine from Pfizer, was initially approved by the FDA in 1987 and is a widely used calcium channel blocker for treating hypertension and angina, with approximately 90% of the drug being metabolized in the liver; its absolute bioavailability is estimated between 64% and 90%, with peak plasma concentrations occurring between 6 and 12 hours after oral administration. Amlodipine, the active ingredient in Norvasc, works by relaxing blood vessels, and it is one of the most prescribed medications worldwide with over 70 million prescriptions in the US in 2022. The medication maintains its blood pressure effect over a 24-hour period, with 93% of the circulating drug being bound to plasma proteins in hypertensive patients. You can find more information about Norvasc on the Pfizer website.
Sandoz
Sandoz, a brand of Novartis, is a well-regarded producer of amlodipine, a medication used to treat high blood pressure and angina. Their amlodipine products are available in various dosages, like 5mg and 10mg tablets, and are often prescribed as a first-line treatment for hypertension. Studies show that amlodipine reaches steady-state plasma levels after 7 to 8 days of daily dosing, with an absolute bioavailability between 64% and 80%. Furthermore, amlodipine is widely distributed, and approximately 97.5% of it binds to plasma proteins. Sandoz Amlodipine is used in adults and children 6 years of age and older. You can find more information about Sandoz amlodipine on the official website of Pharmasave.
Mylan
Mylan, now a part of Viatris, has been a significant producer of amlodipine, a medication used to treat high blood pressure, receiving FDA approval for their generic version in 2005 and holding 180 days of market exclusivity. While 5mg tablets accounted for 58% of the market share in 2023, Mylan offers amlodipine in various strengths and formulations, including combination drugs like Amlodipine/Atorvastatin. Viatris continues to market amlodipine under the brand name Norvasc in the US after acquiring it from Pfizer. Amlodipine's effectiveness is due to its ability to relax blood vessels and improve blood flow, with single daily dosing maintaining effectiveness for 24 hours. You can find more information on the product.
Teva Pharmaceuticals
Teva Pharmaceuticals is a significant global manufacturer of amlodipine, offering it as an FDA-approved generic alternative to brand-name Norvasc, with their amlodipine besylate tablets available in various dosages, including the commonly prescribed 5mg and 10mg tablets. Teva is recognized as a key player in the competitive amlodipine market, which is projected to reach USD 2.53 billion by 2031, driven by the increasing prevalence of hypertension and cardiovascular diseases, with North America holding a 34.56% market share in 2023. Teva's amlodipine products are accessible worldwide, with a presence in markets including the US, Canada, and the UK. You can find more information about Teva's Amlodipine Besylate Tablets, USP.
Lupin Pharmaceuticals
Lupin Pharmaceuticals, a major global pharmaceutical company, is a significant producer of amlodipine, a widely used medication for hypertension, with a strong presence in the US market. Their Amlodipine Besylate tablets are available in 2.5mg, 5mg, and 10mg strengths. The company received FDA approval for its Amlodipine/Benazepril capsules in 2010, further solidifying their commitment to cardiovascular medications. As of 2011, Lupin was ranked second in the US for its share of the overall market for the Amlodipine Benazepril product line. For more information about their Amlodipine Besylate tablets, please visit their website.
Sun Pharmaceutical
Sun Pharmaceutical is a prominent producer of amlodipine, a medication widely used to treat hypertension and angina, offering it in various strengths, including 2.5mg, 5mg, and 10mg tablets. Their products are marketed under brand names like Amlosun and Taro-Amlodipine, as well as authorized generics in the US market, contributing to their significant presence within the antihypertensive medication sector, particularly in North America, where the company also has a manufacturing facility under Ohm Laboratories. Amlodipine, a calcium channel blocker, offers the benefit of a once-daily dosage. Sun Pharma holds a 5.35% market share in the Indian pharmaceutical sector. For more details on their products, visit their website.
Apotex Inc.
Apotex Inc. is a key player in the amlodipine market, offering both 5mg and 10mg tablets, with the 5mg tablets holding a significant share, around 58%, of the market due to their effective composition and lower risk of side effects. Apotex's amlodipine is used to treat hypertension and angina, and they also produce combination medications like Amlodipine and Atorvastatin tablets. The company has been marketing Amlodipine since 2009, and their products are available in various countries. Apotex is recognized as a major company in the global amlodipine besylate market, which is projected to reach USD 2.539 billion by 2031. Additionally, Apotex is committed to quality and safety in pharmaceutical production. You can find more information about their Amlodipine products on their website.
Aurobindo Pharma
Aurobindo Pharma is a leading global manufacturer of amlodipine, producing various strengths, such as 5mg and 10mg tablets, with approvals from the US FDA and other regulatory bodies. Their amlodipine products, often available as amlodipine besylate, are used to treat hypertension and angina, and are manufactured in facilities like their Unit-XV in India. In 2016, they received approval for amlodipine and valsartan tablets, with an estimated market size of $123 million for the 12 months ending in February 2016. Aurobindo has a strong presence in the global market, offering both generic and branded formulations of amlodipine.
Zydus Pharmaceuticals
Zydus Pharmaceuticals is a significant producer of amlodipine, offering it in 2.5mg, 5mg, and 10mg tablet strengths, with US FDA approval since 2007 and a market presence alongside other major manufacturers; they also produce a combination drug containing amlodipine and atorvastatin. As of 2012, amlodipine besylate had estimated sales of $384.8 million, demonstrating its importance in their portfolio. The company continues to provide high-quality generic options in the US, where approximately 90% of prescriptions are filled with generics, ensuring access to affordable medications. You can find more information about their products on their website.
Cipla Limited
Cipla Limited, a key player in the pharmaceutical industry, is recognized as a prominent manufacturer of amlodipine, with a significant market presence; they offer amlodipine besylate tablets, including a widely used 5 mg dosage, and have been manufacturing this medication for many years, adhering to global pharmaceutical standards. Cipla's amlodipine products are distributed worldwide, and they are known for their high-quality manufacturing processes, which are in compliance with Good Manufacturing Practices (GMP); with a focus on cardiovascular health, Cipla's amlodipine helps manage hypertension and angina, demonstrating its commitment to providing essential medicines. You can find more information about Cipla's amlodipine product.
Leave a Reply
Your email address will not be published.